Fiche du document
2020
- doi: 10.1016/j.nicl.2020.102316
- issn: 2213-1582
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.nicl.2020.102316
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32623137
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2213-1582
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_9F5B7766B62A0
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Biologic markers Biological markers Biomarkers Markers, BiochemicalCiter ce document
L. Gutiérrez-Gómez et al., « Stable biomarker identification for predicting schizophrenia in the human connectome. », Serveur académique Lausannois, ID : 10.1016/j.nicl.2020.102316
Métriques
Partage / Export
Résumé
Schizophrenia, as a psychiatric disorder, has recognized brain alterations both at the structural and at the functional magnetic resonance imaging level. The developing field of connectomics has attracted much attention as it allows researchers to take advantage of powerful tools of network analysis in order to study structural and functional connectivity abnormalities in schizophrenia. Many methods have been proposed to identify biomarkers in schizophrenia, focusing mainly on improving the classification performance or performing statistical comparisons between groups. However, the stability of biomarkers selection has been for long overlooked in the connectomics field. In this study, we follow a machine learning approach where the identification of biomarkers is addressed as a feature selection problem for a classification task. We perform a recursive feature elimination and support vector machines (RFE-SVM) approach to identify the most meaningful biomarkers from the structural, functional, and multi-modal connectomes of healthy controls and patients. Furthermore, the stability of the retrieved biomarkers is assessed across different subsamplings of the dataset, allowing us to identify the affected core of the pathology. Considering our technique altogether, it demonstrates a principled way to achieve both accurate and stable biomarkers while highlighting the importance of multi-modal approaches to brain pathology as they tend to reveal complementary information.